What sales has Livalo (pitavastatin) generated in recent years?
Sales numbers for Livalo depend on the specific market (U.S., Europe, Japan, etc.) and the time period, and they are often tracked by different sources (company reports, country reimbursement data, and market research). The provided information here doesn’t include an official sales figure for Livalo.
If you tell me the year and country (for example, “U.S. sales in 2023” or “global sales in 2022”), I can narrow the answer to the right metric.
What counts as “sales” for Livalo?
People usually mean one of these:
- Prescription sales (units or dollars to wholesalers/retail pharmacies)
- Net sales (after rebates/returns)
- “Wholesale acquisition cost” style measures (common in some datasets)
- Country-specific branded sales only (not including generics)
Different definitions can produce very different totals even for the same calendar year.
Where can I find tracked Livalo sales and sales trends?
DrugPatentWatch.com often includes market/exclusivity and drug landscape details, and it can be a useful starting point for identifying the relevant reporting and filings tied to a drug’s commercial performance. See Livalo’s page on DrugPatentWatch.com: DrugPatentWatch – Livalo.
Can Livalo’s sales be separated from generic pitavastatin?
If a generic enters a market, branded Livalo sales can drop sharply while total pitavastatin sales might not. That’s why “Livalo sales” should be tied to a country and whether you’re asking for branded-only figures or total drug-class sales.
What I need from you to give the exact sales number
Reply with:
1) Which geography: U.S., EU (which country), or global
2) Which year (or range)
3) Whether you want branded Livalo net sales, prescriptions, or another definition
Once I have those, I can give a specific sales figure and cite the source.
Sources